本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Castle Biosciences, Inc.

14.65
-0.5000-3.30%
盤後14.650.00000.00%18:05 EDT
成交量:42.16萬
成交額:624.36萬
市值:4.23億
市盈率:-79.41
高:15.16
開:15.16
低:14.61
收:15.15
資料載入中...
2025/06/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report